Skip to content

About Us
Our Science
Partnerships
News

News
READ THE LATEST UPDATES

December 23, 2024 | Press Releases

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

October 9, 2024 | Press Releases

Inmagene to Host Virtual KOL Event on the Inhibition of the OX40/OX40L Signaling in the Treatment of Atopic Dermatitis and Alopecia Areata

June 27, 2024 | Press Releases

Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a Non-covalent Reversible BTK Inhibitor with Once Daily Dosing Potential

3

About Us
Our Science
Partnerships
News

About Us
Our Science
Partnerships
News

Copyright © 2025 Miragene All Rights Reserved

Company

About Us
Our Science
Pipeline
Partnerships
Contact Us

Scroll to Top